CN104273580A - 一种浒苔含片的制作 - Google Patents
一种浒苔含片的制作 Download PDFInfo
- Publication number
- CN104273580A CN104273580A CN201310290517.4A CN201310290517A CN104273580A CN 104273580 A CN104273580 A CN 104273580A CN 201310290517 A CN201310290517 A CN 201310290517A CN 104273580 A CN104273580 A CN 104273580A
- Authority
- CN
- China
- Prior art keywords
- enteromorpha
- preparation
- enteromorpha prolifera
- low
- concentrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007937 lozenge Substances 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 241000196253 Ulva prolifera Species 0.000 title abstract 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 21
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000010447 xylitol Nutrition 0.000 claims abstract description 21
- 239000000811 xylitol Substances 0.000 claims abstract description 21
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 21
- 229960002675 xylitol Drugs 0.000 claims abstract description 21
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 5
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 5
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 5
- 241000196252 Ulva Species 0.000 claims description 46
- 239000012141 concentrate Substances 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 9
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- 238000007598 dipping method Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 235000013372 meat Nutrition 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000314 lubricant Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 235000020995 raw meat Nutrition 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 13
- 235000013305 food Nutrition 0.000 abstract description 13
- 102000004169 proteins and genes Human genes 0.000 abstract description 12
- 108090000623 proteins and genes Proteins 0.000 abstract description 12
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 11
- 239000011707 mineral Substances 0.000 abstract description 11
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 10
- 239000011782 vitamin Substances 0.000 abstract description 9
- 229940088594 vitamin Drugs 0.000 abstract description 9
- 229930003231 vitamin Natural products 0.000 abstract description 9
- 235000013343 vitamin Nutrition 0.000 abstract description 9
- 235000013325 dietary fiber Nutrition 0.000 abstract description 8
- 206010020772 Hypertension Diseases 0.000 abstract description 7
- 235000004213 low-fat Nutrition 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 4
- 235000005911 diet Nutrition 0.000 abstract description 4
- 201000001421 hyperglycemia Diseases 0.000 abstract description 4
- 210000004204 blood vessel Anatomy 0.000 abstract description 3
- 230000000378 dietary effect Effects 0.000 abstract description 3
- 230000000050 nutritive effect Effects 0.000 abstract description 3
- 235000012000 cholesterol Nutrition 0.000 abstract description 2
- 229960004106 citric acid Drugs 0.000 abstract description 2
- 235000008935 nutritious Nutrition 0.000 abstract description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 229940057948 magnesium stearate Drugs 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 14
- 150000001413 amino acids Chemical class 0.000 description 8
- 102000004877 Insulin Human genes 0.000 description 7
- 108090001061 Insulin Proteins 0.000 description 7
- 229940125396 insulin Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- 208000034189 Sclerosis Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 206010020590 Hypercalciuria Diseases 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- -1 carbon fatty acid Chemical class 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 2
- 229960002715 nicotine Drugs 0.000 description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 241000227425 Pieris rapae crucivora Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/37—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种浒苔含片的制作，用到的原料主要为浒苔、木糖醇、麦芽糊精、柠檬酸、硬脂酸镁和崂山矿泉水。现代人的生活不断提高，造成了营养不均衡，饮食结构不合理,产生了高血压、高血脂、高血糖。随着人们对于生活品质的追求不断提高，健康、绿色的食品越来越受到人们的青睐。浒苔是高蛋白、高膳食纤维、低脂肪、低能量，且富含矿物质和维生素的天然理想营养食品的原料。本发明涉及的浒苔含片，保留了浒苔固有的高蛋白、高膳食纤维、低脂肪、低能量、富含矿物质和维生素的营养价值，是一种适用于患有动脉硬化、高血压、糖尿病、三高血症患者人群食用的，除能降血脂、降胆固醇、糖尿病治疗，软化血管的绿色保健食品。
Description
技术领域 本发明涉及一种浒苔含片的制作，用到的原料主要为浒苔、木糖醇、麦芽糊精、柠檬酸、硬脂酸镁和崂山矿泉水。现代人的生活不断提高，造成了营养不均衡，饮食结构不合理,产生了高血压、高血脂、高血糖。随着人们对于生活品质的追求不断提高，健康、绿色的食品越来越受到人们的青睐。浒苔富含碳水化合物、蛋白质、粗纤维及矿物质，同时还含有脂肪和维生素。在浒苔蛋白质中，氨基酸种类齐全，必需氨基酸含量较高，其中缘管浒苔的限制氨基酸为赖氨酸，氨基酸评分为79；条浒苔的限制氨基酸为蛋氨酸，氨基酸评分为80。浒苔的脂肪酸组成中，多不饱和脂肪酸、单不饱和脂肪酸和饱和脂肪酸的含量为分别为50.5%、12.7%和36.8%，其中包括近4%的奇数碳原子脂肪酸。因此浒苔是高蛋白、高膳食纤维、低脂肪、低能量，且富含矿物质和维生素的天然理想营养食品的原料。浒苔的纤维质有解毒烟碱的作用，对吸烟者有好处。浒苔的碘含量也很高。本发明涉及的浒苔含片，保留了浒苔固有的高蛋白、高膳食纤维、低脂肪、低能量、富含矿物质和维生素的营养价值，是一种除能降血脂、降胆固醇、糖尿病治疗，软化血管的绿色保健食品。特别适用于患有动脉硬化、高血压、糖尿病、三高血症患者人群食用。
背景技术 随着现代人的生活不断提高，造成了营养不均衡，饮食结构不合理；既追求吃得精、吃得香。嘴吃香了，身体却受影响了，出现了三高三低症状，产生了高血压、高血脂、高血糖，肥胖人群不断增加。高血脂是体内胆固醇和甘油三酯增多，可以造成头晕，心脑血管的硬化。高血脂肯定会引起心血管疾病，特别是甘油三酯，是独立危险因素；有胸痛、心慌、房颤这些症状可能已经有冠心病存在了，不排除仅仅只是心律失常，血脂高了，血液中的垃圾也就多，导致了血管壁增厚，血液流速慢，血压增高，心脏供血不足就会导致心痛、心慌等；一般建议最好还是食疗的比较好。因此人们一直在寻求一种高蛋白、高膳食纤维、低脂肪、低能量，并且富含矿物质和维生素等天然绿色养生食品。本发明提供的这种浒苔含片，氨基酸种类齐全，必需氨基酸含量较高，膳食纤维丰富，脂肪含量低，能量低，富含各种矿物质和天然维生素，可以辅助补充碘份，携带方便，是一种适合动脉硬化、高血压、糖尿病、三高血症患者人群食用的绿色保健食品。
发明内容 本发明的要点在于将浒苔→漂洗→脱腥→粉碎→加水热浸提→保温→粗滤→硅藻土过滤机→真空浓缩锅→浓缩液→与其他辅料混合→混合机造粒→干燥→压片→灭菌→包装成为一种浒苔含片。
本发明选用的材料用量如下（组分及其重量百分比％）：浒苔30.0-40.0；木糖醇50.0-60.0；麦芽糊精10.0-15.0；柠檬酸1.0；硬脂酸镁4‰。
浒苔：浒苔富含碳水化合物、蛋白质、粗纤维及矿物质，同时还含有脂肪和维生素。在浒苔蛋白质中，氨基酸种类齐全，必需氨基酸含量较高，其中缘管浒苔的限制氨基酸为赖氨酸，氨基酸评分为79；条浒苔的限制氨基酸为蛋氨酸，氨基酸评分为80。浒苔的脂肪酸组成中，多不饱和脂肪酸、单不饱和脂肪酸和饱和脂肪酸的含量为分别为50.5%、12.7%和36.8%，其中包括近4%的奇数碳原子脂肪酸。因此浒苔是高蛋白、高膳食纤维、低脂肪、低能量，且富含矿物质和维生素的天然理想营养食品的原料。
木糖醇：木糖醇做糖尿病人的甜味剂、营养补充剂和辅助治疗剂：木糖醇是人体糖类代谢的中间体，在体内缺少胰岛素影响糖代谢情况下，无须胰岛素促进，木糖醇也能透过细胞膜，被组织吸收利用，促进肝糖元合成，供细胞以营养和能量，且不会引起血糖值升高，消除糖尿病人服用后的三多症状（多食、多饮、多尿），是最适合糖尿病患者食用的营养性的食糖代替品。木糖醇能促进肝糖元合成，血糖不会上升，对肝病患者有改善肝功能和抗脂肪肝的作用，治疗乙型迁延性肝炎，乙型慢性肝炎及肝硬化有明显疗效，是肝炎并发症病人的理想辅助药物。木糖醇的防龋齿特性在所有的甜味剂中效果最好，首先是木糖醇不能被口腔中产生龋齿的细菌发酵利用，抑制链球菌生长及酸的产生；其次在咀嚼木糖醇时，能促进唾液分泌，唾液多了既可以冲洗口腔、牙齿中的细菌，也可以增大唾液和龋齿斑点处碱性氨基酸及氨浓度，同时减缓口腔内PH值下降，伤害牙齿的酸性物质被中和稀释，抑制了细菌在牙齿表面的吸附，从而减少了牙齿的酸蚀，防止龋齿和减少牙斑的产生，巩固牙齿。木糖醇为人体提供能量，合成糖元，减少脂肪和肝组织中的蛋白质的消耗，使肝脏受到保护和修复，减少人体内有害酮体的产生，不会因食用而为发胖忧虑。可广泛用于食品、医药、轻工等领域。 木糖醇与普通的白砂糖相比，具有热量低的优势——每克木糖醇仅含有2.4卡路里热量，比其他大多数碳水化合物的热量少40%，因而木糖醇可被应用于各种减肥食品中，作为高热量白糖的代用品。生物木糖醇在体内代谢缓慢，因此它不会使胰岛素突然上升或下降，普通食糖则会，木糖醇是胰岛素的天然稳定剂，食品用后不会增加血液中胰岛素，木糖醇还扮演着稳定激素的重要角色，高指标水平胰岛素会增加雌激素产生，引起乳腺癌也干扰了卵巢的健康功能，胰岛素阻抗是产生激素问题（多囊卵巢综合症）的重要原因；所以降低胰岛素水平至关重要不仅对抵抗多囊卵巢综合症而且对分解更多其他激素的不平衡降低乳癌风险有重要意义。
本发明生产工艺: 浒苔→漂洗→脱腥→粉碎→加水热浸提→保温→粗滤→硅藻土过滤机→真空浓缩锅→浓缩液→浓缩液与其他辅料混合→混合机造粒→干燥→压片→灭菌→包装。
本发明产品的制备方法是：
1）预处理：浒苔洗净、脱腥、切碎、烘干，粉碎机破碎成细粉；
2）热浸提取：将浒苔细粉放入夹层锅中，加30倍量的崂山矿泉水，热水浸提（90-100度）并保温4小时；
3）过滤：先用60目滤网粗滤，再经过硅藻土过滤机进行细滤；
4）浓缩：把滤液输入真空浓缩锅（真空度97kPa，温度55左右），将液体浓缩至原加水量1/20时，成为浒苔浓缩液；
5）将浒苔浓缩液和其他辅料按一定比例充分混合；
6）混合充分的软料投入摇摆式颗粒剂中进行造成粒，再把颗粒放在真空干燥机中进行干燥，真空度控制在0.053-0.060Mpa，温度控制在60-65度使颗粒的水分控制在小于3%左右；
7）在干燥颗粒中加入润滑剂（硬脂酸镁，4‰）混匀后，压片，紫外线下照射30分钟，然后及时包装。
本发明具有以下优点：
1）保留了浒苔固有的高蛋白、高膳食纤维、低脂肪、低能量、富含矿物质和维生素的营养价值；
2）起到降血脂、降胆固醇、糖尿病治疗，软化血管等功效；
3）辅助补充碘份；
4）条浒苔的纤维质有解毒烟碱的作用，对吸烟者有好处；
5）木糖醇取代蔗糖，既不会引起血糖值升高，也可以防止龋齿的发生；
6）特别适用于患有动脉硬化、高血压、糖尿病、三高血症患者人群食用。
具体实施方式：下面结合实施例对本发明作进一步的详细说明：
以100kg本发明产品为例：
1．配方：（组分及其重量百分比％）：浒苔30.0-40.0；木糖醇50.0-60.0；麦芽糊精10.0-15.0；柠檬酸1.0；硬脂酸镁4‰。
2. 生产流程: 浒苔→漂洗→脱腥→粉碎→加水热浸提→保温→粗滤→硅藻土过滤机→真空浓缩锅→浓缩液→浓缩液与其他辅料混合→混合机造粒→干燥→压片→灭菌→包装。
3.制备方法：
1）预处理：浒苔洗净、脱腥、切碎、烘干，粉碎机破碎成细粉；
2）热浸提取：将浒苔细粉放入夹层锅中，加水量30倍，热水浸提（90-100度）并保温4小时；
3）过滤：先用60目滤网粗滤，再经过硅藻土过滤机进行细滤；
4）浓缩：把滤液输入真空浓缩锅（真空度97kPa，温度55左右），将液体浓缩至原加水量1/20时，成为浒苔浓缩液；
5）将浒苔浓缩液和其他辅料按一定比例充分混合；
6）混合充分的软料投入摇摆式颗粒剂中进行造成粒，再把颗粒放在真空干燥机中进行干燥，真空度控制在0.053-0.060Mpa，温度控制在60-65度使颗粒的水分控制在小于3%左右；
7）在干燥颗粒中加入润滑剂（硬脂酸镁，4‰）混匀后，压片，紫外线下照射30分钟，然后及时包装。
Claims (3)
1.本发明涉及一种浒苔含片的制作方法，其特征在于具有如下配方（组分及其重量百分比%）：
浒苔30.0-40.0；木糖醇50.0-60.0；麦芽糊精10.0-15.0；柠檬酸1.0；硬脂酸镁4‰。
2. 一种权利要求1所述的浒苔含片的制作方法，其特征在于具有如下的生产工艺：
浒苔→漂洗→脱腥→粉碎→加水热浸提→保温→粗滤→硅藻土过滤机→真空浓缩锅→浓缩液→浓缩液与其他辅料混合→混合机造粒→干燥→压片→灭菌→包装。
3. 一种权利要求1所述的浒苔含片的制作方法，其特征在于具有如下的制备方法：
1）预处理：浒苔洗净、脱腥、切碎、烘干，粉碎机破碎成细粉；
2）热浸提取：将浒苔细粉放入夹层锅中，加水量30倍，热水浸提（90-100度）并保温4小时；
3）过滤：先用60目滤网粗滤，再经过硅藻土过滤机进行细滤；
4）浓缩：把滤液输入真空浓缩锅（真空度97kPa，温度55左右），将液体浓缩至原加水量1/20时，成为浒苔浓缩液；
5）将浒苔浓缩液和其他辅料按一定比例充分混合；
6）混合充分的软料投入摇摆式颗粒剂中进行造成粒，再把颗粒放在真空干燥机中进行干燥，真空度控制在0.053-0.060Mpa，温度控制在60-65度使颗粒的水分控制在小于3%左右；
7）在干燥颗粒中加入润滑剂（硬脂酸镁，4‰）混匀后，压片，紫外线下照射30分钟，然后及时包装。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310290517.4A CN104273580A (zh) | 2013-07-11 | 2013-07-11 | 一种浒苔含片的制作 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310290517.4A CN104273580A (zh) | 2013-07-11 | 2013-07-11 | 一种浒苔含片的制作 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104273580A true CN104273580A (zh) | 2015-01-14 |
Family
ID=52249319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310290517.4A Pending CN104273580A (zh) | 2013-07-11 | 2013-07-11 | 一种浒苔含片的制作 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104273580A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104814436A (zh) * | 2015-05-18 | 2015-08-05 | 福建农林大学 | 一种石莼科藻类功能性低聚糖复合咀嚼片 |
-
2013
- 2013-07-11 CN CN201310290517.4A patent/CN104273580A/zh active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104814436A (zh) * | 2015-05-18 | 2015-08-05 | 福建农林大学 | 一种石莼科藻类功能性低聚糖复合咀嚼片 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100463614C (zh) | 保健糌粑及其生产方法 | |
| CN102726565A (zh) | 荞菊养生茶及其制备方法 | |
| CN1742927A (zh) | 枸杞桑椹片及其制备工艺 | |
| KR20150051020A (ko) | 비만억제 및 다이어트 조성물 | |
| CN104664370A (zh) | 一种亚麻咀嚼片 | |
| CN107752024A (zh) | 一种改善三高及肥胖等代谢异常疾病的营养代餐食品 | |
| CN100358992C (zh) | 以鱼腥草为原料生产的酒及其制备方法 | |
| CN103040054A (zh) | 大蒜功能饮料及其制备方法 | |
| CN109090597A (zh) | 一种辅助降三高组合物及其制备方法和应用 | |
| CN107372985A (zh) | 一组适合糖尿病人群服食的以结晶果糖为甜味剂的果糖巧克力 | |
| CN106511641A (zh) | 一种具有治疗痛风功效的青梅纳豆组合物及其制备方法 | |
| CN108812792A (zh) | 一种无糖荞麦饼干 | |
| CN103859399B (zh) | 一种玉米须营养保健食品及其制备方法 | |
| CN104106828A (zh) | 一种降血糖的固体饮料 | |
| CN103263054B (zh) | 一种降血压功能性饮品 | |
| CN105341300A (zh) | 一种适宜儿童食用的保健糖果 | |
| CN102018158A (zh) | 一种芦荟果酱 | |
| CN104273580A (zh) | 一种浒苔含片的制作 | |
| KR20170109380A (ko) | 밀웜을 함유한 양갱의 제조방법 및 이에 따라 제조된 밀웜 양갱 | |
| CN104799277A (zh) | 一种阿胶口嚼片及其制备方法 | |
| CN105995980B (zh) | 一种具有体重管理作用的组合物及其制备方法 | |
| CN101993806B (zh) | 一种海马、海蛇、海参复配酒的制备方法 | |
| KR102198434B1 (ko) | 천연식물을 이용한 고지혈증 예방 또는 치료용 약학 조성물, 그 제조방법 및 제제 | |
| CN106107288A (zh) | 一种桑葚南瓜复合果汁保健饮料及其制备方法 | |
| CN115553409A (zh) | 一种补充骨髓营养的固体饮料及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150114 |